13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market
13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
  1. Home
  2. Insider Trading
  3. Menzel Garry E

Menzel Garry E

CIK: 0001556064
Director
Primary company: TCR2 THERAPEUTICS INC. (TCRR)

Menzel Garry E is a corporate insider at TCR2 THERAPEUTICS INC. (TCRR) filing SEC Form 4 transactions. 85 transactions across 6 companies, totaling $0 in purchases and $145,312 in sales. Source: SEC EDGAR.

Total Transactions
85
Total Buy Value
$0
Total Sell Value
$145K
Net Activity
$-145K
Last Transaction
Jun 2025
Companies
6

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Company
Type
Shares
Price
Value
Shares After
Date
SEC
Black Diamond Therapeutics, Inc.
BDTX
Award30,550--30,550
6/12/2025
Filed: 6/12/2025
Filing →
Stoke Therapeutics, Inc.
STOK
Award29,747--29,747
6/3/2025
Filed: 6/4/2025
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award1,121,604--1,121,604
7/1/2024
Filed: 7/1/2024
Filing →
Stoke Therapeutics, Inc.
STOK
Award7,639--7,639
6/5/2024
Filed: 6/7/2024
Filing →
Black Diamond Therapeutics, Inc.
BDTX
Award30,550--30,550
6/6/2024
Filed: 6/6/2024
Filing →
Adaptimmune Therapeutics PLC
ADAP
Sale47,702$0.91$43K75,056
7/10/2023
Filed: 7/10/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award2,158,776$0.00$02,158,776
7/5/2023
Filed: 7/5/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award2,715,816$0.00$02,715,816
7/5/2023
Filed: 7/5/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award57,846$0.00$057,846
7/5/2023
Filed: 7/5/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award3,568,026$0.00$03,568,026
7/5/2023
Filed: 7/5/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award359,700$0.00$0359,700
7/5/2023
Filed: 7/5/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award1,251,966$0.00$01,251,966
7/5/2023
Filed: 7/5/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award736,548$0.00$0736,548
7/5/2023
Filed: 7/5/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award981,463$0.00$0981,463
7/3/2023
Filed: 7/3/2023
Filing →
Stoke Therapeutics, Inc.
STOK
Award19,441$0.00$019,441
6/13/2023
Filed: 6/15/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award209,931--209,931
6/1/2023
Filed: 6/1/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award200,647--200,647
6/1/2023
Filed: 6/1/2023
Filing →
Adaptimmune Therapeutics PLC
ADAP
Award200,646--200,646
6/1/2023
Filed: 6/1/2023
Filing →
TCR2 THERAPEUTICS INC.
TCRR
Disposition39,681$0.00$00
6/1/2023
Filed: 6/1/2023
Filing →
TCR2 THERAPEUTICS INC.
TCRR
Disposition23,165$0.00$00
6/1/2023
Filed: 6/1/2023
Filing →
Black Diamond Therapeutics, Inc.
BDTX
Type
Award
Shares
30,550
Price
-
Value
-
Stoke Therapeutics, Inc.
STOK
Type
Award
Shares
29,747
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
1,121,604
Price
-
Value
-
Stoke Therapeutics, Inc.
STOK
Type
Award
Shares
7,639
Price
-
Value
-
Black Diamond Therapeutics, Inc.
BDTX
Type
Award
Shares
30,550
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
47,702
Price
$0.91
Value
$43K
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
2,158,776
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
2,715,816
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
57,846
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
3,568,026
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
359,700
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
1,251,966
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
736,548
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
981,463
Price
$0.00
Value
$0
Stoke Therapeutics, Inc.
STOK
Type
Award
Shares
19,441
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
209,931
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
200,647
Price
-
Value
-
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
200,646
Price
-
Value
-
TCR2 THERAPEUTICS INC.
TCRR
Type
Disposition
Shares
39,681
Price
$0.00
Value
$0
TCR2 THERAPEUTICS INC.
TCRR
Type
Disposition
Shares
23,165
Price
$0.00
Value
$0
AI Agent

Try asking...

FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market